期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

桃核承气改良方对家兔血管内皮损伤后信号转导及转录活化因子3和NO的影响

下载PDF
导出
作者 张雨 宫丽鸿 时广容 徐琳
机构地区 辽宁中医药大学 辽宁中医药大学附属医院
出处 《中草药》 CAS CSCD 北大核心 2008年第9期1382-1385,共4页 Chinese Traditional and Herbal Drugs
基金 辽宁省教育厅高等学校科学研究项目(05L246)
关键词 信号转导和转录活化因子 血管内皮损伤 转录活化因子3 经皮冠状动脉腔内成形术 NO 家兔 良方 承气
分类号 R531.8 [医药卫生—内科学] R543 [医药卫生—心血管疾病]
  • 相关文献

参考文献11

  • 1刘占军,徐耕.Cilostazol与经皮冠状动脉介入术后再狭窄的防治[J].国际心血管病杂志,2006,33(3):150-152. 被引量：6
  • 2张勇,娄桂予,钱民章.建立兔高脂血症模型及动脉粥样硬化斑块的方法[J].遵义医学院学报,2001,24(4):304-306. 被引量：47
  • 3Bauters C, Meurice T, Hamon M, et al. Mechanisms and preven-tion of restenosis: from experimental models to clinical practice [J]. Cardiovasc Res, 1996, 31(6): 835-846.
  • 4Rensing B J, Vos J, Smits P C, et al. Coronary restenosis elimina-tion with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up [J]. Eur Heart J, 2001, 22(22): 2125-2130.
  • 5Mosea J W, O'Shaughnessy C, Capito R, et al. The US multicenter, randomized, double blind study of the sirolimuseluting stent in coronary lesions: safety out comes at 9 months [J]. Eur Heart J, 2002, 23(Suppl): 264.
  • 6Hoey T, Grusby M J. STAT3 as mediators of cytokine- induced response [J]. Adv Immunol, 1998, 71: 145-160.
  • 7Osugi T, Oshima Y, Fujio Y, et al. Cardiacospecific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart [J]. J Biol Chem, 2002, 277(8): 6676-6681.
  • 8Yu X, Kennedy R H, Liu S J. JAK2/STAT3, not ERK1/2 pathway mediates inter leukin 6-elicited inducible NOS activation and decrease in contractility in adult ventricular myocytes [J]. J Biol Chem, 2003, 278(18): 16304-16309.
  • 9Yamauchi2Takihara K. Gp130-mediated pathway and left ventricular remodeling [J]. J Card Fail, 2002, 8(6 Suppl) : S374-S378.
  • 10Indolfi C, Mongiardo A, Curcio A, et al. Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stentsl Trends [J]. Cardiovasc Med, 2003, 13 : 142-148.

二级参考文献16

  • 1[1]Kariyazono H,Nakamura K,Shinkawa T,et al.Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol[J].Thromb Res,2001,101 (6):445-453.
  • 2[3]Tanabe Y,Ito E,Nakagawa I,et al.Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine[J].Int J Cardiol,2001,78(3):285-291.
  • 3[4]Nakamura T,Houchi H,Minami A,et al.Endothelium-dependent relaxation by cilostazol,a phosphodiesteras Ⅲ inhibitor,on rat thoracic aorta[J].Life Sci,2001,69 (15):1709-1715.
  • 4[5]Ito C,Kusano E,Akimoto T,et al.Cilostazol enhances IL1beta-induced NO production and apoptosis in rat vascular smooth muscle via PKA-dependent pathway[J].Cell Signal,2002,14(7):625-632.
  • 5[6]Morishita R.A scientific rationale for the CREST trial results:Evidence for the mechanism of action of cilostazol in restenosis[J].Atheroscler,(Suppl):2005.
  • 6[7]Diep QN,El Mabrouk M,Cohn JS,et al.Structure,endothelial function,cell growth,and inflammation in blood vessels of angiotensin Ⅱ-infused rats:role of peroxisome proliferator-activated receptor-gamma[J].Circulation,2002,105(19):2296-2302.
  • 7[8]Freeman EJ.The Ang Ⅱ-induced growth of vascular smooth muscle cells involves a phospholipase D-mediated signaling mechanism[J].Arch Biochem Biophys,2000,374 (2):363-370.
  • 8[9]Takai S,Jin D,Nishimoto M,et al.Cilostazol suppresses intimal formation in dog grafted veins with reduction of angiotensin Ⅱ-forming enzymes[J].Eur J Pharmacol,2001,411(3):301-304.
  • 9[10]Tsuchikane E,Kobayashi T,Kobayashi T,et al.Debulking and stenting versus debulking only of coronary artery disease in patients treated with cilostazol (final results of ESPRIT)[J].Am J Cardiol,2002,90(6):573-578.
  • 10[11]Tanigawa T,Nishikawa M,Kitai T,et al.Increased platelet aggregability in response to shear stress in acute myocardial infarction and its inhibition by combined therapy with aspirin and cilostazol after coronary intervention[J].Am J Cardiol,2000,85(9):1054-1059.

共引文献49

中草药
2008年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部